Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Earlier versions of a spending cuts package passed through Congress targeted PEPFAR. But the White House, concerned about ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...

PEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...